Addex Therapeutics (ADXN) Return on Capital Employed (2022 - 2025)
Historic Return on Capital Employed for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to 0.68%.
- Addex Therapeutics' Return on Capital Employed fell 3000.0% to 0.68% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.68%, marking a year-over-year decrease of 3000.0%. This contributed to the annual value of 0.4% for FY2024, which is 2700.0% up from last year.
- Per Addex Therapeutics' latest filing, its Return on Capital Employed stood at 0.68% for Q3 2025, which was down 3000.0% from 0.6% recorded in Q2 2025.
- In the past 5 years, Addex Therapeutics' Return on Capital Employed registered a high of 5.86% during Q1 2024, and its lowest value of 6.96% during Q1 2023.
- Its 4-year average for Return on Capital Employed is 1.62%, with a median of 0.65% in 2024.
- Its Return on Capital Employed has fluctuated over the past 5 years, first soared by 128200bps in 2024, then tumbled by -64100bps in 2025.
- Quarter analysis of 4 years shows Addex Therapeutics' Return on Capital Employed stood at 5.42% in 2022, then skyrocketed by 73bps to 1.49% in 2023, then surged by 68bps to 0.47% in 2024, then plummeted by -43bps to 0.68% in 2025.
- Its last three reported values are 0.68% in Q3 2025, 0.6% for Q2 2025, and 0.54% during Q1 2025.